Cargando…
A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor
Tyrosine kinase inhibitors (TKI) are known to be highly effective in the treatment of various cancers with kinase-domain mutations such as chronic myelogenous leukemia. However, they have important side effects such as increased vascular permeability and pulmonary hypertension. In patients undergoin...
Autores principales: | Haumann, Renard G, Buys, Dedré, Hofland, Eline, Romijn, Hans WA, Kamminga, Suzanne K, Aman, Jurjan, Nossent, Esther J, Symersky, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932616/ https://www.ncbi.nlm.nih.gov/pubmed/34962840 http://dx.doi.org/10.1177/02676591211052161 |
Ejemplares similares
-
Dynamic vascular changes in chronic thromboembolic pulmonary
hypertension after pulmonary endarterectomy
por: Ruigrok, Dieuwertje, et al.
Publicado: (2020) -
Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?
por: Bogaard, Harm Jan, et al.
Publicado: (2022) -
Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
por: Braams, Natalia J., et al.
Publicado: (2023) -
Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
por: Ruigrok, Dieuwertje, et al.
Publicado: (2022) -
Riociguat inhibits ultra‐large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients
por: Jujo Sanada, Takayuki, et al.
Publicado: (2022)